Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The International Menopause Society celebrates another milestone.

Climacteric : the journal of the International Menopause Society·2026

Same author

Frailty and menopause: A gateway to healthy aging.

Maturitas·2026

Same author

Beyond recurrence detection: Treating the forgotten menopause in endometrial cancer survivors.

European journal of obstetrics, gynecology, and reproductive biology·2026

Same author

Soft Tissue Reconstruction Does Not Compromise Infection Control in Chronic Knee Periprosthetic Joint Infection Treated with Two-Stage Exchange Arthroplasty Despite Increasing Complexity.

Microorganisms·2026

Same author

Associations Between Reproductive Disorders and Specific Physical, Mental, Personality, and Social Characteristics: A Narrative Review.

Health science reports·2026

Same author

Pregnancy and perinatal complications in untreated subfertile couples following singleton spontaneous conception: a narrative review.

Reproductive biology and endocrinology : RB&E·2026

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Isoflavones and cardiovascular disease.

Antonio Cano¹, Miguel Angel García-Pérez, Juan José Tarín

¹Department of Pediatrics, Obstetrics and Gynecology, University of Valencia and Hospital Universitario Dr Peset, Valencia, Spain. Antonio.cano@uv.es

|August 24, 2010

Summary

Isoflavones, similar to estrogens, show cardiovascular benefits by limiting atherogenesis. Research suggests they may reduce atherosclerotic burden, though clinical trials on cardiovascular events are lacking.

Related Experiment Videos

Last Updated: Jun 10, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Area of Science:

Cardiovascular Science
Endocrinology
Nutraceuticals

Background:

Estrogens offer cardiovascular protection, primarily by limiting atherogenesis, but their effect on cardiovascular events is less clear.
Isoflavones, acting as estrogen receptor agonists, present a potential avenue for improving cardiovascular risk profiles.

Purpose of the Study:

To systematically review experimental and clinical data on the cardiovascular effects of isoflavones.
To compare the cardiovascular benefits of isoflavones with those of estrogens.

Main Methods:

Systematic literature search of Medline database and reference lists of review papers.
Inclusion of experimental data from cell cultures, isolated arteries, and animal models (including non-human primates).
Inclusion of clinical data assessing lipid profiles, insulin resistance, hemostasis, inflammatory markers, and endothelial function indicators.

Main Results:

Experimental and clinical data suggest isoflavones exhibit cardiovascular benefits similar to estrogens.
Studies indicate potential improvements in lipid profiles, insulin resistance, and endothelial function.
Emerging evidence suggests isoflavones may reduce atherosclerotic burden, as evidenced by decreased intima-media thickness.

Conclusions:

Isoflavones demonstrate a promising cardiovascular protective profile, comparable to estrogens.
Further research, including randomized controlled trials, is needed to confirm the impact of isoflavones on clinical cardiovascular events.